Autosomal Dominant Hypocalcemia clinical trials at UCSF
1 research study open to eligible people
Showing trials for
CLARIFY: ADH1 and ADH2 Disease Monitoring Study (DMS)
open to eligible people ages up to 90 years
A global, multi-center, non-interventional Disease Monitoring Study (DMS) in participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1) or Autosomal Dominant Hypocalcemia Type 2 (ADH2) designed to characterize ADH1 and ADH2 disease presentation and progression through retrospective (past) and longitudinal prospective (over time into the future) data collection.
Oakland, California and other locations